Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy

Clement What the numbers say about this buyer

• 27% of the bids received came from small and medium-sized enterprises (315 procedures with a bid mix). Country: 65%.n = 315
• 44% of this buyer's awards went to companies that had already won here before (2,657 awards since 2019, spread over 1,069 companies). 56% went to new names.n = 2,657 awards since 2019
• The median procedure drew 2 bids (1,674 procedures with a bid count); 39% ended with a single bidder. Country: median 2.2 bids.n = 1,674
• The award came in at a median 93% of the estimated value (9 awards with both estimate and value) — pricing at the estimate is usually too high here. Country: 88%.n = 9
• 9% of awards went to companies from abroad (2,657 awards with a known winner country). National average: 5%.n = 2,657
• Across 12 procedures with structured selection criteria, this buyer most often required: Special authorisation or membership required (11 of 12), References: supplies (1 of 12).n = 12
• < 1% of the bids received came from other countries (315 procedures with a bid mix) — all bidders, not just the winners. Country: 2%.n = 315

From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 01/11/2026.